Fudan University

Fudan University logo
🇨🇳China
Ownership
Private
Established
1905-01-01
Employees
1K
Market Cap
-
Website
http://www.fudan.edu.cn

A Study of Apatinib in Non-triple-negative Metastatic Breast Cancer

Phase 2
Completed
Conditions
Interventions
First Posted Date
2012-07-31
Last Posted Date
2013-12-03
Lead Sponsor
Fudan University
Target Recruit Count
20
Registration Number
NCT01653561
Locations
🇨🇳

Fudan University Cancer Hospital, Shanghai, China

Induction Chemotherapy Followed by Concurrent Radiation With Cetuximab or Cisplatin in Locally Advanced Nasopharyngeal Cancer

First Posted Date
2012-06-08
Last Posted Date
2012-06-08
Lead Sponsor
Fudan University
Target Recruit Count
46
Registration Number
NCT01614938
Locations
🇨🇳

Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China

Serum Proteomic Profiling for the Early Diagnosis of Colorectal Cancer

Completed
Conditions
Interventions
First Posted Date
2012-05-24
Last Posted Date
2012-05-24
Lead Sponsor
Fudan University
Target Recruit Count
547
Registration Number
NCT01604798
Locations
🇨🇳

Zhongshan Hospital, Fudan University, Shanghai, Shanghai, China

Study on FOLFOX6 as First-line Therapy to Treat Recurrent or Metastatic Esophageal Cancer

Phase 2
Completed
Conditions
Interventions
First Posted Date
2012-05-24
Last Posted Date
2012-05-24
Lead Sponsor
Fudan University
Target Recruit Count
60
Registration Number
NCT01605305

A Phase III Study of Comparing Paclitaxel Plus 5-Fluorouracil Versus Cisplatin Plus 5-Fluorouracil in Chemoradiotherapy for Locally Advanced Esophageal Carcinoma

First Posted Date
2012-05-03
Last Posted Date
2018-10-18
Lead Sponsor
Fudan University
Target Recruit Count
436
Registration Number
NCT01591135
Locations
🇨🇳

Fudan University Cancer Center, Shanghai, Shanghai, China

A Phase II Study of Abraxane Gemcitabine Combination in Patients With Metastatic Breast Cancer

Phase 2
Completed
Conditions
Interventions
First Posted Date
2012-03-12
Last Posted Date
2015-09-09
Lead Sponsor
Fudan University
Target Recruit Count
84
Registration Number
NCT01550848
Locations
🇨🇳

Fudan University Cancer Hospital, Shanghai, China

IL-6 and IL-8 Level of Blood and Pleural Effusion During Chemotherapy in Metastatic Breast Cancer

Terminated
Conditions
First Posted Date
2012-03-02
Last Posted Date
2013-07-26
Lead Sponsor
Fudan University
Target Recruit Count
9
Registration Number
NCT01543126
Locations
🇨🇳

Fudan University Cancer Hospital, Shanghai, China

Salvage Chemotherapy of Vinorelbine Plus Oxaliplatin in Metastatic Triple-negative Breast Cancer:a Prospective Trial

First Posted Date
2012-02-08
Last Posted Date
2012-02-08
Lead Sponsor
Fudan University
Target Recruit Count
35
Registration Number
NCT01528826
Locations
🇨🇳

Fudan University Cancer Center, Shanghai, Shanghai, China

Docetaxel With or Without Metronomic Cyclophosphamide as First Line Chemotherapy in Metastatic Breast Cancer

First Posted Date
2012-02-06
Last Posted Date
2012-02-07
Lead Sponsor
Fudan University
Target Recruit Count
60
Registration Number
NCT01526499
Locations
🇨🇳

Fudan University Cancer Hospital, Shanghai, Shanghai, China

Low Dose of Metronomic Cyclophosphamide and Capecitabine in Pretreated HER2-negative Metastatic Breast Cancer

Phase 2
Conditions
Interventions
First Posted Date
2012-02-06
Last Posted Date
2012-02-07
Lead Sponsor
Fudan University
Target Recruit Count
72
Registration Number
NCT01526512
Locations
🇨🇳

Fudan University Cancer Center, Shanghai, Shanghai, China

© Copyright 2024. All Rights Reserved by MedPath